Trailing-twelve-month (TTM) revenue is $659.62 Million with a year-over-year growth of +22.80%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $150,842,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-14 |
| Q4 FY2025Period ended 2025-12-31 | $154,799,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-13 |
| Q1 FY2026Period ended 2026-03-31 | $176,439,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14 |
| Q2 FY2026Period ended 2026-06-30 | $177,540,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $659,620,000 |
Current P/S: $1,220,564,822 market capitalization ÷ $659,620,000 TTM revenue = 1.85x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T17:35:08.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $177.54M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:37:00.081Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|
| Real Estate | $8M | N/A |
| Service Other | $357,000 | N/A |
| United Kingdom Segment | N/A | $51M |
| United States Segment | N/A | $450M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20252025-12-31 · USD |
|---|---|
| Canada Segment | $72M |
| Latin America Segment | $40M |
$659.62M
$659.62 Million
+22.80%
vs. $537.15M a year ago (TTM)
+54.92%
5 Year compound annual growth rate
1 Year
+22.80%
3 Year
N/A
5 Year
+54.92%
10 Year
+65.58%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $613.29M | +$179.99M | +41.54% |
| 2024 | $433.30M | +$110.23M | +34.12% |
| 2023 | $323.07M | +$277.98M | +616.46% |
| 2019 | $45.09M | +$13.88M | +44.46% |
| 2018 | $31.21M | +$19.02M | +156.04% |
| 2017 |
TTM Growth
+22.80%
3-Year CAGR
N/A
5-Year CAGR
+54.92%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 17 comparable quarters.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $12.19M |
| +$5.66M |
| +86.64% |
| 2016 | $6.53M | +$4.79M | +274.76% |
